Results 151 to 160 of about 139,045 (309)

Supplemental Figure S1 from Cell State Transitions Drive the Evolution of Disease Progression in B-Lymphoblastic Leukemia

Curtis Gravenmier, Sadegh Marzban, Yi-Han Tang, Nancy Gillis, Bijal D. Shah, Lynn C. Moscinski, Ling Zhang, Jeffrey West   +7 more
openalex   +1 more source

CB‐103: A novel CSL‐NICD inhibitor for the treatment of NOTCH‐driven T‐cell acute lymphoblastic leukemia: A case report of complete clinical response in a patient with relapsed and refractory T‐ALL

, 2022
Michael Medinger, Till Junker, Dominik Heim, Alexandar Tzankov, Philip Jermann, María Bobadilla, Michele Vigolo, Rajwinder Lehal, Florian D. Vogl, Michael Bauer, Jakob Passweg   +10 more
openalex   +1 more source

Ectopic expression of BEX genes in T-cell acute lymphoblastic leukemia. [PDF]

Blood Adv
Quessada J, Nozais M, Grosjean C, Savey C, Pankaew S, Allelova S, Potier D, Loosveld M, Payet-Bornet D.   +8 more
europepmc   +1 more source

A genome-wide CRISPR/Cas9 screen reveals novel positive regulators of FTY720 sensitivity in acute lymphoblastic leukemia cells

Jaira F. de Vasconcellos, Leah Friedman, Isha Satapathy, Nicole Cubbage, Jasmin Palmer, Saurav Majumder, Mari Kono   +6 more
openalex   +1 more source

EphA3 as a target for antibody immunotherapy in acute lymphoblastic leukemia [PDF]

, 2016
Sara Charmsaz, Fares Al‐Ejeh, Trina Yeadon, Kirrilee J Miller, Fiona Smith, Brett W. Stringer, Andrew S. Moore, F. T. Lee, L Cooper, Con Stylianou, Geoffrey Yarranton, John Woronicz, Andrew M. Scott, Martin Lackmann, Andy Boyd   +14 more
openalex   +1 more source

Burden of haematological malignancies among children, adolescents and young adults: Global and high‐income region insights from the GBD 2021 study

British Journal of Haematology, EarlyView.
Summary This study provides a comprehensive assessment of haematological malignancies among children, adolescents and young adults aged 0–24 years, using data from the Global Burden of Disease 2021 across 204 countries from 1990 to 2021. We found that global incidence and prevalence remained relatively stable, with approximately 150 000 new cases and ...
Shujuan Xu, Baihua Yang, Xinxin Liu, Zhenshu Xu, Ping Weng   +4 more
wiley   +1 more source

Cerebrovascular complications in pediatric patients with acute lymphoblastic leukemia. [PDF]

Sci Rep
Rocka A, Lesniak M, Majka P, Lipniarska J, Suchcicka M, Lejman M, Wozniak M, Zawitkowska J.   +7 more
europepmc   +1 more source

Aurora A kinase as a target for therapy in <i>TCF3-HLF</i> rearranged acute lymphoblastic leukemia

, 2021
Jessica Leonard, Joelle Wolf, Michelle Degnin, Christopher A. Eide, Dorian LaTocha, Kyle Lenz, Beth Wilmot, Charles G. Mullighan, Mignon L. Loh, Stephen P. Hunger, Brian Druker, Marc Loriaux, Jeffrey Tyner, Bill H. Chang   +13 more
openalex   +2 more sources

Hyper-CVAD in Adults With Acute Lymphoblastic Leukemia in Ecuador: A Multicenter Retrospective Study. [PDF]

Adv Hematol
Sabando B, Quinonez J, Orquera A, Navarrete D, Ramírez J, Sanchez L, Chisesi T, Oliveros J, Pacheco MA, Trujillo MC, Plaza C, Loor Y.   +11 more
europepmc   +1 more source

Assessment of measurable residual disease in ovarian tissue collected for fertility preservation in patients in remission from acute myeloid leukaemia: A pilot study

British Journal of Haematology, EarlyView.
Summary Allogeneic haematopoietic stem cell transplantation (ASCT) is a curative treatment for acute myeloid leukaemia (AML) but carries a high risk of gonadotoxicity. Ovarian tissue cryopreservation (OTC) offers a fertility preservation option, yet its safety in AML remains uncertain due to the risk of leukaemic cell reintroduction. The FERTILAM pilot
Augustin Boudry, Florian Chevillon, Alice Marceau‐Renaut, Thorsten Braun, Thomas Boyer, Nathalie Helevaut, Elise Fournier, Sandrine Geffroy, Nicolas Boissel, Emmanuelle Clappier, Claude Preudhomme, Nicolas Duployez, Catherine Poirot, Laurène Fenwarth   +13 more
wiley   +1 more source